id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2007-E-0229-0006,FDA,FDA-2007-E-0229,Determination of Regulatory Review Period for Purposes of Patent Extension; TYKERB,Notice,N-Notice,2008-11-10T05:00:00Z,2008,11,2008-11-10T05:00:00Z,2009-01-10T04:59:59Z,2008-11-12T17:20:22Z,E8-26679,0,0,09000064807a13a5
FDA-2007-E-0229-0005,FDA,FDA-2007-E-0229,FDA/CDER to the USPTO - Letter,Other,LET-Letter,2008-11-03T05:00:00Z,2008,11,2008-11-03T05:00:00Z,,2008-11-12T17:21:02Z,,0,0,090000648078da63
FDA-2007-E-0229-0002,FDA,FDA-2007-E-0229,SmithKline Beecham Corporation - Patent Term Extension Application,Other,APP-Application,2008-10-31T04:00:00Z,2008,10,2008-10-31T04:00:00Z,,2008-10-31T18:30:48Z,,0,0,090000648042ae79
FDA-2007-E-0229-0004,FDA,FDA-2007-E-0229,FDA/CDER to the USPTO - Letter,Other,LET-Letter,2008-10-31T04:00:00Z,2008,10,2008-10-31T04:00:00Z,,2008-11-12T17:21:47Z,,0,0,09000064806fb1ef
FDA-2007-E-0229-0003,FDA,FDA-2007-E-0229,FDA/CDER to the USPTO - Letter,Other,LET-Letter,2008-10-31T04:00:00Z,2008,10,2008-10-31T04:00:00Z,,2008-11-12T17:22:22Z,,0,0,090000648053dbd8